Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5873_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
27 Мб
Скачать
Chapter 8
Inflammation and the skin: dermatitis, psoriasis, and acne
Useful terms for this topic
Atopy: A genetic disposition to hypersensitivity or
allergic states, characterized by high IgE antibody levels.
Eczema/dermatitis: Inammatory condition of the
skin. Terms are often used interchangeably, although eczema is sometimes reserved for atopic dermatitis.
Emollient: Substance that moisturizes the skin.
Epidermis: Outer layer of the skin.
Langerhans cells: Specialized cells in the epidermis
that engulf foreign pathogens, and then process and present them to cells of the immune system to initiate the inammatory response.
Keratinocytes: Main cell type in the epidermis.
Contains keratin, a brous protein which gives strength to the epidermis.
Pruritus: Itching.
Vehicle: The bulk phase which carries the drug.
Skin conditions, such as those covered in this chapter, account for between 10% and 20% of consultations in general practice in the UK. As well as causing much discomfort, they can have a signicant psychological impact on the patient, particularly when aecting visible areas such as the face or hands. Some of these disorders are associated with particular phases in our lives, for instance acne, which aects up to 90% of
teenagers, and can lead to acute embarrassment and social isolation.
Elvis, our ctional patient in Workbook 5, like many suerers of dermatitis, or inammation of the skin, has an inherited disposition to developing classic allergic diseases. Such individuals are described as atopic and may be aected by the related conditions, asthma and allergic rhinitis. Elvis suered dermatitis as a baby and asthma as a young child, and, as we shall see, as a teenager he is again aected by atopic dermatitis. (Atopic dermatitis is frequently referred to as eczema, although this term is often used interchangeably with dermatitis, describing all such inammatory conditions of the skin, irrespective of the trigger, see Section 8.3.)
In this chapter, and the workbook that follows, we consider the underlying pathology, symptoms, and treatment of three common skin conditions: dermatitis, psoriasis, and acne. First, though, we must look at the skin’s structure and physiology, an understanding of which will guide the eective management of these conditions. Of particular signicance to the treatment of skin conditions is the pharmaceutical formulation of topically applied drugs. Some agents are available in a range of dierent preparations, the suitability of which will need to be determined on an individual basis, depending on symptoms. ese aspects of medication applied topically to the skin are also explored in the current chapter.
184 Chapter 8 Inflammation and the skin: dermatitis, psoriasis, and acne
Dermal papillae
Hair
Pore

8.1 Structure and physiology of the skin

e skin is the body’s largest organ, constituting about 16% of body weight. Its main functions are:
• protection against heat, light, injury and
infection
• regulation of body temperature
• retention of water
• biochemical synthesis (e.g. vitamin D)
• sensory detection.
e skin has three main layers: the outermost epidermis, the dermis, and the deeper subcutaneous, or hypodermis (Figure 8.1). e composition of these layers is described in more detail in Box 8.1. e epidermal layer is largely composed of specialized cells called keratinocytes, and constantly renews itself as cells migrate from the basal cell layer, where they are formed, to eventually slough o at the surface. As they make this journey the characteristics of keratinocytes change; their keratin
content increases and they lose intracellular organelles. e thickness of the skin is determined by the depth of the epidermal layer, and varies around the body; for instance, it is much thicker on the palms of the hands and soles of the feet. is is of importance for the absorption of topically applied drugs into the circulation, which is signicantly greater where skin is thin, increasing the risk of adverse eects. In addition to keratinocytes, the epidermis contains two other important cell types.
1. Melanocytes are responsible for secreting the pigment melanin, which determines the skin’s coloration.
2. Langerhans cells, or dendritic cells, are part of the immune system and engulf invading foreign material. ese cells act as antigen presenting cells, processing parts of the pathogen, which they present on their surface to lymphocytes at local lymph nodes, thereby initiating the immune response. ey are central to the development of eczema/dermatitis.
Epidermis
Dermis
Subcutaneous layer
Arrector pili muscle
Sebaceous gland
Figure 8.1 The structure of the skin.
The layers of the skin and associated structures, including a hair follicle with a sebaceous gland.
Sweat gland
Cold receptor
Heat receptor
Blood vessel
Connective tissue
Nerve
Fat lobules
8.1 Structure and physiology of the skin 185
Keratinocyte migration
Box 8.1
Layers of the skin
1. The epidermis
e epidermis or outer layer of the skin acts as a protective barrier, and is composed mainly of keratinocytes. It is made up of distinct sublayers through which cells migrate (see Figure a). As they make this journey, the cells undergo keratinization, a process in which they express increasing amounts of the brous protein keratin. is protein forms thick cable-like structures connecting cells together, and lending strength to the epidermis.
Stratum basale (stratum germinativium) Immature keratinocytes are formed in the division of column­shaped stem cells in this, the deepest layer of the epidermis.
Stratum spinosum e migrating cells begin the process of keratinization; the keratin bres give the cytoplasm a spiny, or prickly, appearance. is layer is deeper where skin is thick.
Stratum granulosum Keratinocytes take on a polyhedral shape, with a more granular cytoplasm
and increased amounts of keratin. ey begin to atten and to lose intracellular organelles, such as the nucleus. is layer is three to ve cells thick.
Stratum lucidum is is found only in regions where the skin is particularly thick, such as the soles of the feet, and is made up of dead cells. It serves to reduce friction and shear forces between the stratum granulosum and the stratum corneum.
Stratum corneum e cells in this layer have a full complement of keratin, and have lost organelles. ese mature keratinocytes are attached together laterally, providing strength. ey are attened, and the outermost cells are dead and are shed at the surface. e layer can be between three and twenty cells deep, depending on the skin’s thickness. e stratum corneum allows absorption of water to keep the skin hydrated. e migration of keratinocytes, starting at the stratum basale and ending as they are sloughed o at the skin’s surface, normally takes about a month. is is accelerated in psoriasis (see below).
and maturation
Dead keratinocytes at surface slough off, replaced by cells
Stratum
corneum
Stratum lucidum Stratum
granulosum
Stratum
spinosum
Stratum
basale
Stratum corneum
Stratum
lucidum
Stratum
granulosum
Stratum
spinosum
Stratum
basale
Dermis
from beneath.
Mature keratinocytes with keratin cables making up ~85% of protein content. Cells are attened and anuclear.
Maturing cells migrate to surface, attening and losing organelles. Increased keratin content forms strong cable structures.
Stem cells divide to form immature keratinocytes— keratin makes up about 30% of their protein.
Figure a The layers of the epidermis.
The arrows indicate the migration of keratinocytes, continuously being formed in the stratum basale, to the surface of the skin, where in mature form they make up the majority of the stratum corneum.
Adapted from Gray H, Anatomy of the Human Body (20th edn), 1918. Philadelphia: Lea & Febiger.
186 Chapter 8 Inflammation and the skin: dermatitis, psoriasis, and acne
Box 8.1 Layers of the skin
2. The dermis
e much thicker dermis, beneath the epidermis, is composed mainly of connective tissue, and imparts pliability and protection from mechanical injury. It is also the site of vitamin D synthesis. Its rich vascular network supplies nutrients and oxygen to the epidermal layer, which lacks blood vessels. Additional structures include:
• sweat and sebaceous glands (see below)
• hair follicles—downward growths of the epidermis
which produce hair, involved in temperature regulation; when the body gets cold, the associated arrector pili muscle contracts and the hair stands up, helping to reduce heat loss
• local lymph nodes
• nerve bres and free nerve endings responsible for
sensing temperature change, pain, and itchiness
• receptors for touch, pressure, and vibration.
e glands of the skin are located in the dermis, secreting product through the epidermis to the surface. ey comprise two main types, sweat and sebaceous glands.
e sweat glands can be divided into three groups.
1. Eccrine glands produce a thin watery sweat, secreted on to the skin’s surface to promote heat loss through evaporation. ey are the most common sweat glands, and are particularly abundant in thick skin such as on the palms of the hands and soles of the feet, as well as the forehead. Secretion is stimulated by changes in body temperature and by emotional stimuli, such as stress, anxiety, and pain. e innervating sympathetic neurons are unusual in that they release acetylcholine, not noradrenaline, and this
acts at M3 receptors. Activation of these receptors accounts for the unwanted sweating associated with the use of some medications, such as the muscarinic agonist bethanacol used for urinary retention. Similarly, drugs with antimuscarinic action, for instance atropine and hyoscine, commonly cause dry skin.
2. Apocrine glands open into the upper portion of a hair follicle rather than directly onto the skin’s surface. ey have a more limited distribution and are primarily located in the armpits. e secretion produced is thicker, and is rich in proteins and lipids which undergo decomposition by bacteria, generating products with strong odours. Eccrine glands express adrenoceptors rather than cholinergic receptors, and increased secretion occurs in response to emotional stimuli, such as stress, anxiety, and pain. ese glands are inactive until puberty when hormonal changes lead to their stimulation.
3. Apoeccrine glands have characteristics of both eccrine and apocrine glands. ey have been identied in more hairy regions, such as armpits, and are known to appear during puberty, although their function is as yet unclear.
e sebaceous glands are intimately associated with hair follicles (see Figure 8.1). ey secrete oily sebum which acts as a natural moisturizer. ey are under hormonal control, with secretions also increasing at puberty; overactivity of these glands underlies the development of acne (see Section 8.7).
3. The subcutaneous layer
Also called the subcutis, or hypodermis, this layer is made up of adipose and connective tissue. It acts as a protective cushion and is involved in temperature regulation by providing insulation.

8.2 Medication for topical application to the skin

e prevalence of some of the more common diseases aecting the skin is set out in Table 8.1. Treatment of these disorders aims not only to alleviate the underlying cause of the damage, but also to restore the skin’s normal function. With respect to the latter,
pharmacologically inert agents, e.g. emollients, play a central and crucial role, restoring the appearance and integrity of the skin, and reducing symptoms such as itching. Drugs used in the treatment of skin conditions are often available in a number of forms; selecting the
8.3 Eczema/dermatitis 187
Table 8.1 Prevalence of common skin conditions and the sites most often affected
Clinical diseases Common locations Prevalence (%)
Dermatitis and eczema Seborrhoeic dermatitis: scalp, face, and ears 10
Dermatitis: neck and elbows 7–30
Acne Face, chest, upper back, and arms 22–33 (80–90 in teenagers)
Psoriasis Head, ears, and elbows 1–3
Viral warts Hands and feet 1–16
Skin cancer Exposed skin 0.3
Fungal and bacterial infections Anywhere 10–20
most appropriate preparation must take into account not only the type of skin condition, but also the nature of the symptoms.
8.2.1 Vehicles used in topical preparations
Preparations of drugs to be applied topically to the skin usually consist of the active ingredient mixed in a bulk phase, or vehicle. Drugs may be available in dierent vehicles, and so choice of product will be determined by suitability for the particular skin disorder, as well as the symptoms present. For example, ointments are generally better for the treatment of dry skin conditions, as they aid rehydration. e properties and uses of dierent vehicles are explored further in Box 8.2. Choice of vehicle should also take into account patient preference, as this will inuence compliance.
8.2.2 Factors influencing the absorption of
drugs from topical preparations
In the treatment of skin diseases the aim is to largely restrict delivery of drug to the skin, avoiding absorption into the systemic circulation. Sometimes, though, the skin
is used as a route of administration of systemically acting drugs. In this case, the rate and extent of absorption of a drug applied topically to the skin is determined by a number of factors.
1. Characteristics of the drug, such as water solubility and molecular weight; low molecular weight drugs (e.g. <600 Da) are better absorbed than larger molecules.
2. e vehicle used (see comments in Box 8.2).
3. Skin thickness, with more drug being absorbed from thin skin (e.g. scalp and face) than from thick skin (e.g. palms and soles of the feet).
4. Skin hydration, e.g. vehicles with an ointment or emulsion (especially water-in-oil) base increase hydration. Applying to hydrated skin after a bath also increases absorption.
5. Skin condition, as damaged skin (e.g. in burns or psoriasis) will allow greater absorption.

8.3 Eczema/dermatitis

e terms eczema and dermatitis are often used interchangeably to describe a chronic inammation of the epidermis and dermis that is accompanied by pruritus (itching) and localized oedema of the epidermis, creating a swollen patch of skin, called spongiosis. Other features include redness, dry skin, which is often thickened in the areas that have been rubbed or scratched, red lumps or blisters, weeping lesions, or crusty deposits (Figure 8.2). Excessively dry and thickened skin is described as lichenied.
Dermatitis is often subdivided, based on the causal factor, or irritant.
Atopic dermatitis is the most prevalent form, and is
also the most common skin condition in children, aecting 10–20%, most usually with an onset before the age of 5. (e term eczema is sometimes reserved for atopic dermatitis.) e areas of aected skin are commonly on the inside of the elbows and backs of the knees (exures). Atopy refers to the genetic disposition to hypersensitivity or allergic states, characterized by
188 Chapter 8 Inflammation and the skin: dermatitis, psoriasis, and acne
Box 8.2
Choice of vehicle in the treatment of skin conditions
In treating skin conditions, both the active drug and the vehicle it is delivered in are important. e choice of vehicle depends on a number of factors (Table B8.2). Its characteristics will aect the degree of rehydration of the skin, and therefore also penetration of the drug; it may also have an anti-
Table B8.2 Properties and uses of vehicles for skin conditions
Vehicle Physical and chemical
Ointment Water miscible; can be washed off Lubricates, e.g. in burn dressings
Creams Oil-in-water; washable Well absorbed
Paste Stiff preparation of finely powdered
Powder Drying and cooling
Gels Semi-solid preparations, usually
Lotions Suspensions of powder in water, or
a
Intertriginous areas: where two surfaces of the skin are normally in contact, such as between fingers and toes, armpits.
properties
Water immiscible; not easily washed off
Water-in-oil; acts similarly to ointments; less greasy than ointments, but more greasy than oil-in-water creams
solid, suspended in ointment Very adhesive
Reduces friction between opposing skin surfaces Absorbs moisture and creates increased area for evaporation
aqueous Clear and quick drying No residue
dilute emulsion of oil-in-water
Characteristics and uses Examples
Aids penetration of drugs
Chronic dry skin conditions Messy
Cosmetically acceptable, easy to apply Vehicle for water-soluble drugs Suitable for moist or weeping lesions
Increases skin hydration Vehicle for fat-soluble drugs
Able to absorb discharge (e.g. pus) Protects inflamed, lichenified, and damaged skin
Intertriginousa areas and chronically damp areas (e.g. feet and under nappy)
Useful in hairy areas or where residue is unacceptable (e.g. face)
Superficial oozing dermatoses Intertriginousa areas, inflammation and tenderness (e.g. sunburn, acute contact dermatitis)
inammatory eect. Cosmetic factors must also be considered. For example, creams may be more suitable for daytime use because they are lighter, cosmetically more acceptable, and easier to apply than greasier ointments, which may be reserved for use at night.
Macrogels and PEG mixtures Emulsifying ointment
White soft paraffin Paraffin-based ointments
Aqueous cream BP Cetomacrogol cream
Oily cream BP Zinc cream
Zinc oxide pastes
Talcum powder Antifungal powders
Polymers and copolymers
Calamine lotion
high IgE antibody levels. Approximately half of children with atopic dermatitis will go on to develop other atopic conditions, such as allergic rhinitis and asthma (the ‘atopic triad’; see Chapters 10 and 11). Langerhans
cells, specialized immune cells in the epidermis, detect and capture pathogens pervading the skin barrier, and play a central role in the development of atopic dermatitis. ey migrate to local lymph nodes and
8.4 Treatment of dermatitis 189
Figure 8.2 Appearance of skin affected by dermatitis.
(A) Reddened and inflamed skin at wrists. (B) Classic appearance of contact dermatitis.
(A) From Saxe N, Jessop S, Todd G, Handbook of Dermatology for Primary Care (2nd edn), 2007. By permission of Oxford University Press. (B) © DermNetNZ.
present the antigen/allergen to lymphocytes, thereby initiating typical 2-mediated immune responses with antibody generation as a central feature (see Figure P3.2 in the Introduction to Part 3). Pruritus is the most common symptom of atopic dermatitis, often preceding the appearance of a rash. Open lesions may follow spontaneously, but more usually result from scratching. A number of factors can aggravate atopic dermatitis, including temperature extremes, irritants such as bubble bath, food, or inhaled allergens, or stress. Acute are-ups often result from invasive bacterial or viral infection. Approximately 60% of aected children are symptom free by the age of 16.
Allergic contact dermatitis is a hypersensitivity
reaction resulting from contact with an allergen to which the individual has previously been sensitized, such as latex or nickel.

8.4 Treatment of dermatitis

e strategy for management of dermatitis should include both avoidance of triggers, where these have been identied, and medication. Here we focus on treatment involving emollients and two classes of drugs (corticosteroids and calcineurin inhibitors). Antihistamines may also be useful to ease symptoms such as itching (see Chapter 10, Section 10.2.1). A non-sedating antihistamine is usually preferred, but where symptoms interfere with sleep, one with sedative action may be chosen.
Irritant contact dermatitis can follow contact with
irritants such as detergents, cleaning agents, plastics, etc. ere is no immunological basis to this form of dermatitis.
Photoallergic/phototoxic dermatitis is due to
conversion of chemicals into allergens or toxins in the skin when exposed to UV light.
Seborrhoeic dermatitis aects areas of the skin rich in
sebaceous glands, most commonly the scalp, and areas of the face such as around the nose, between the eyebrows, and behind the ears. Babies’ scalps are often aected (cradle cap). Skin rst appears red and aky, with greasy patches and yellow scales developing. e condition often results from overgrowth of the yeast Pityosporum ovale. Treatment typically involves antifungal agents.
8.4.1 Emollients
In dermatitis the integrity of the skin is compromised as a result of both the inammatory process itself, and damage inicted by scratching. Emollients, creams, and ointments which hydrate and soothe the skin are rst-line treatment for dermatitis. e aim is to adequately rehydrate the stratum corneum and restore the skin’s barrier function, protecting against allergens and irritants. is will also reduce itching.
190 Chapter 8 Inflammation and the skin: dermatitis, psoriasis, and acne
A variety of emollients are available, ranging from light aqueous creams, which are cosmetically more acceptable, to the more occlusive,1 but greasier and messier, ointments. Some preparations contain urea and propylene glycol to improve penetration by loosening the keratinocyte layer, while others contain humectants that attract and retain water, such as glycerin. Application frequency varies with type; creams require more frequent application than ointments.
Emollients should be applied liberally, making issues such as appearance on the skin, smell, eect on clothing, and ease of removal important in the choice of preparation. ey are often under-used, and patients may need counselling to ensure that sucient quantities are applied regularly, thereby reducing the likely need for topical corticosteroids.
8.4.2 Corticosteroids
When emollients are insucient to manage dermatitis, topical preparations of corticosteroids are extremely useful agents.
Mechanism of action
concentration present, and product choice will depend on the severity of the skin disease, as well as the site aected. Potent and very potent steroids should be avoided on delicate thin skin, such as on the face or genitals. Where a steroid is available in more than one type of preparation, the choice of product may also need to take into account the vehicle’s suitability for the symptoms (see Box 8.2 for the signicance of dierent vehicles).
Key principles for the use of topical corticosteroids
A number of points are worth noting to guide the correct use of corticosteroids in order to gain maximum benet, whilst minimizing the risk of unwanted eects.
• Use only when sustained and correct use of emollients
has proved ineective. When introduced they should be used alongside emollients (see next point).
• Apply to hydrated skin (e.g. after bathing, or after use of
an emollient) for maximum penetration and eect.
• Apply thinly to aected area only, and no more
frequently than twice daily.
• Use the least potent formulation possible, and for as
short a time as possible (usually no more than 2 weeks).
Corticosteroids are anti-inammatory agents which enter cells and bind to intracellular receptors (see Chapter 2, Section 2.2.6). e receptor–steroid complex acts within the nucleus to change gene expression, suppressing pro­inammatory genes and inducing expression of anti­inammatory genes (see Chapter 9, Section 9.3.2 and Box 9.2, for more details of the mechanism of action of corticosteroids). e overall eect is a dampening down of the processes underlying dermatitis (see Box 8.3). As a consequence of their mode of action, the therapeutic response is slow to develop, requiring regular application over a sustained period.
Corticosteroids can provide long-term relief, but do not oer a cure; for example, the tendency of an atopic individual to develop dermatitis will not be modied, and when treatment is halted, symptoms may well recur.
Differences in steroid preparations
Topical corticosteroids are classied according to potency, or strength, into four main groups (Table 8.2). Potency depends on the nature of the steroid together with the
1 Occlusive here means a preparation which, when applied to the skin, acts as a physical barrier. is is achieved by thick and greasy preparations.
• Use low- or medium-strength preparations where long-
term treatment is necessary.
• Use low-strength steroids where the skin is thin (e.g.
face), to avoid excessive absorption and the increased risk of side eects.
Side effects of topical steroids
With careful use systemic effects from topical corticosteroids can be avoided, even with high potency preparations. Local adverse effects are more common, particularly at the site of application of the stronger agents. The local suppression of the immune response may lead to infection, thinning of the skin, striae (stretch-mark-like damage), and telangiectasia (visible dilated blood vessels). Topical corticosteroids have also been known to precipitate acne. Rebound effects, with enhanced symptoms of the underlying skin condition when treatment is stopped, are also of concern.
A short course of an oral corticosteroid such as
prednisolone may be justied to control severe acute
eczema. Owing to the risk of side eects (see above), such treatment does not feature in the long-term management of the condition.
8.4 Treatment of dermatitis 191
Box 8.3
Development and treatment of atopic dermatitis
Damaged stratum corneum
Penetration of antigen
Helper
T-cell
Th2 cell
Antigen-specic IgE
Mediators of inammation Pro-inammatory
cytokines
Inammation, itching, discomfort, weeping. Decient epidermal barrier water loss dehydration itching and scratching
APC
B-cell
+ve feedback
Mast cell
activation
Figure b A scheme for the development and perpetuation of atopic
dermatitis.
Figure b provides a simplified illustration of how damaged epidermis, infiltration by antigens, and the inflammatory response contribute to the symptoms of atopic dermatitis, and give rise to a pattern of self-perpetuating feedback.
Treatment of atopic dermatitis targets dierent aspects of the disease process.
Emollients restore the condition of the epidermis, rehydrating it to establish an eective barrier to water loss, and reducing penetration of allergens and
irritants. Itching is reduced and the skin’s appearance becomes more normal.
Corticosteroids alter gene expression to increase the levels of anti-inammatory proteins, and decrease pro-inammatory proteins. e result is a dampening